Cargando…
Axillary lymphadenopathy in a high-risk breast screening patient following the COVID-19 vaccine: a diagnostic conundrum
A number of COVID-19 vaccines have been approved worldwide to help tackle the pandemic. As with many vaccines, this causes a reactive axillary lymphadenopathy which can mimic potentially metastatic disease in a breast screening patient. It is therefore important to be aware of this side-effect of th...
Autores principales: | Musaddaq, Besma, Brown, Adam, Dluzewski, Sam, Marafioti, Teresa, Malhotra, Anmol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Institute of Radiology.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906153/ https://www.ncbi.nlm.nih.gov/pubmed/35300233 http://dx.doi.org/10.1259/bjrcr.20210063 |
Ejemplares similares
-
Co-existent breast malignancy and contralateral primary axillary tuberculosis
por: Dluzewski, Sam, et al.
Publicado: (2022) -
Unilateral axillary adenopathy following COVID-19 vaccination: a multimodality pictorial illustration and review of current guidelines
por: Brown, A., et al.
Publicado: (2021) -
Presumed pulmonary COVID-19 infection detected incidentally on breast MR
por: Brown, Adam, et al.
Publicado: (2020) -
Axillary lymphadenopathy following bivalent COVID-19 booster vaccination
por: Lane, Elizabeth G., et al.
Publicado: (2023) -
COVID-19 VACCINATION-ASSOCIATED LYMPHADENOPATHY: A DIAGNOSTIC CONUNDRUM IN LUNG CANCER STAGING
por: ELSHAKH, HADYA, et al.
Publicado: (2022)